Integrated BioTherapeutics (United States)
- World rank, 2022-now
- #22,362 of 22,385 · #28,853 all time
- Rank in United States
- #3,325 of 3,332
- Research works
- 239 ▲ 78% vs 2018-21
- Citations
- 4.4k 18.4 per fractional work
- Top-10% rate
- 7.7% all institutions 10.0%
- vs its own fields
- 0.93× 1.00× is exactly expected
- Open access
- 44% world 40%
- International
- 17% world 18%
Which fields of science does Integrated BioTherapeutics (United States) work in?
In 2022-now, 51% of research at Integrated BioTherapeutics (United States) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (18%). It does 2.7× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 20 fields, with their numbers
- Health Sciences4351.2%
- Medicine4250.4%
- Health Professions00.6%
- Dentistry00.1%
- Nursing00.1%
- Veterinary00.1%
- Life Sciences3541.5%
- Physical Sciences66.9%
- Engineering44.9%
- Computer Science10.7%
- Materials Science00.5%
- Chemistry00.3%
- Energy00.2%
- Mathematics00.2%
- Environmental Science00.1%
- Social Sciences00.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.6×. Every wedge is a field page.
All 20 fields, with their numbers
- Immunology and Microbiology17.57×15 works
- Biochemistry, Genetics and Molecular Biology4.06×18 works
- Medicine2.62×42 works
- Neuroscience1.16×2 works
- Pharmacology, Toxicology and Pharmaceutics0.56×0 works
- Veterinary0.48×0 works
- Engineering0.33×4 works
- Dentistry0.27×0 works
- Energy0.22×0 works
- Health Professions0.22×0 works
- Chemistry0.20×0 works
- Nursing0.20×0 works
- Mathematics0.17×0 works
- Materials Science0.14×0 works
- Computer Science0.09×1 works
- Economics, Econometrics and Finance0.09×0 works
- Environmental Science0.03×0 works
- Arts and Humanities0.02×0 works
- Psychology0.02×0 works
- Agricultural and Biological Sciences0.01×0 works
- Immunology and Microbiology 17.6×
- Biochemistry, Genetics and Molecular Biology 4.1×
- Medicine 2.6×
- Neuroscience 1.2×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Veterinary 0.5×
- Engineering 0.3×
- Dentistry 0.3×
- Energy 0.2×
- Health Professions 0.2×
- Chemistry 0.2×
- Nursing 0.2×
- Mathematics 0.2×
- Materials Science 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Environmental Science 0.0×
- Arts and Humanities 0.0×
- Psychology 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Integrated BioTherapeutics (United States)?
Ranked on the quality score, M. Javad Aman, Sergey Shulenin and Frederick W. Holtsberg lead among researchers whose main affiliation is Integrated BioTherapeutics (United States).
- 1
M. Javad Aman
United States · #190,155 worldwide 8.9k citations · 163 works
- 2
Sergey Shulenin
United States · #442,537 worldwide 3.4k citations · 52 works
- 3
Frederick W. Holtsberg
United States · #476,693 worldwide 4.4k citations · 80 works
- 4
Sven G. Enterlein
United States · #552,519 worldwide 1.8k citations · 27 works
- 5
Katie A. Howell
United States · #673,723 worldwide 866 citations · 21 works
- 6
Hong Vu
United States · #707,509 worldwide 1.8k citations · 46 works
- 7
Alexander Kamb
United States · #721,819 worldwide 17k citations · 163 works
- 8
Eric J. Stavale
United States · #870,224 worldwide 1.2k citations · 22 works
- 9
Breanna DiAndreth
United States · #950,150 worldwide 831 citations · 29 works
- 10
Rajan P. Adhikari
United States · #1,238,715 worldwide 1.6k citations · 37 works
Which keywords describe research at Integrated BioTherapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, Leukemia, Glycosylation, CAR T Cells and Chimeric Antigen Receptor.
- Arginine Deprivation
- CD4+CD25+
- HER2
- Viral Vectors
- PET Imaging
- AAV
- Clinical Trials
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- NK Cell Recognition
- Vaccine Adjuvants
- Dendritic Cells
- Antigen Presentation
- Immunity
- Innate Immunity
- Fc Receptors
- Glycosylation
- CAR T Cells
- Leukemia
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- Lymphoma
- Chimeric Antigen Receptor
- Monoclonal Antibodies
- Therapeutic Antibodies
- Tumor Microenvironment
- Epidemiology
- Gene Therapy
- Tumor Antigen
- Targeted Therapy
- Natural Killer Cells
- Monoclonal Antibody
- Chemotherapy
- Tumor Targeting
- Cancer Therapy
- TGF-ß
- Breast Cancer
- Trastuzumab
- Foxp3
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy14▲ 108×3 topics
- Immunotherapy13▲ 22×10 topics
- Tumor Regression11▲ 113×2 topics
- Leukemia9▲ 133×2 topics
- Lymphoma9▲ 70×3 topics
- CAR T Cells9▲ 147×1 topic
- Chimeric Antigen Receptor9▲ 147×1 topic
- Glycosylation9▲ 98×3 topics
- Monoclonal Antibodies8▲ 107×2 topics
- Fc Receptors8▲ 163×1 topic
- Therapeutic Antibodies8▲ 128×1 topic
- Innate Immunity7▲ 25×6 topics
- Tumor Microenvironment6▲ 16×8 topics
- Immunity6▲ 17×5 topics
- Epidemiology6▲ 1.63×23 topics
- Antigen Presentation5▲ 70×2 topics
- Gene Therapy5▲ 31×4 topics
- Dendritic Cells5▲ 65×2 topics
- Tumor Antigen5▲ 94×1 topic
- Vaccine Adjuvants5▲ 94×1 topic
- Targeted Therapy4▲ 22×5 topics
- NK Cell Recognition4▲ 73×1 topic
- Natural Killer Cells4▲ 73×1 topic
- Immune Checkpoint Blockade3▲ 31×1 topic
- Monoclonal Antibody3▲ 65×2 topics
- PD-1 and PD-L13▲ 31×1 topic
- Chemotherapy3▲ 4.9×8 topics
- Clinical Trials3▲ 4.8×7 topics
- Tumor Targeting3▲ 17×3 topics
- AAV2▲ 64×1 topic
- Cancer Therapy2▲ 4.4×8 topics
- PET Imaging2▲ 15×3 topics
- TGF-ß2▲ 15×3 topics
- Viral Vectors2▲ 64×1 topic
- Breast Cancer2▲ 8.9×4 topics
- HER22▲ 67×1 topic
- Trastuzumab2▲ 43×1 topic
- CD4+CD25+2▲ 60×1 topic
- Foxp32▲ 60×1 topic
- Arginine Deprivation2▲ 50×1 topic
Which research topics does Integrated BioTherapeutics (United States) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 9 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 8 works
- 3 Immunotherapy and Immune Responses Immunology 5 works
- 4 Immune Cell Function and Interaction Immunology 4 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 6 Virus-based gene therapy research Genetics 2 works
- 7 HER2/EGFR in Cancer Research Oncology 2 works
- 8 T-cell and B-cell Immunology Immunology 2 works
- 9 Cancer Research and Treatments Biotechnology 2 works
- 10 Cancer Genomics and Diagnostics Cancer Research 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Integrated BioTherapeutics (United States)'s research output changed?
Output in 2022-2025 was 78% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Integrated BioTherapeutics (United States) as a percentage of every work published that year, 0.00029% in 2024.
Fractional works of Integrated BioTherapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- Robotic Research (United States)
- GenVec
- CVPath Institute
- Identity
- Altimmune (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Integrated BioTherapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
